search
Back to results

Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis (STONE)

Primary Purpose

Urolithiasis, Urologic Diseases, Urinary Calculi

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Percutaneous Nephrostomy
Double J catheter
Sponsored by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Urolithiasis focused on measuring Urolithiasis, Urologic Diseases, Urinary Calculi, Urinary Obstruction, Urinary Stone, Nephrostomy; Complications, Catheter Complications, double j catheter, JJ catheter, urinary stent, percutaneous nephrostomy, stent

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

- In order to be considered eligible to participate in this study, a subject must meet all of the following criteria:

  • Male/female >18 year
  • Symptoms and/or laboratory results indicating obstructive kidney disease with or without infection.
  • A kidney or ureteral stone is present on ultrasound or CT (max 3 months old prior to presentation)
  • Both drainage techniques are feasible and safe in opinion of the treating physician (from logistics point of view and in the best interest of the patient).
  • Willing and able to comply with filling in questionnaires and follow-up regiment

Exclusion Criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • Analphabetic or not mastering the Dutch language
  • Pregnancy
  • Usage of anticoagulation agents other than acetylsalicylic acid.
  • Contraindication for either technique looking at history and anatomy (e.g. kidney transplant, pouch, Bricker deviation, urethral or ureteral stenosis)

Sites / Locations

  • Amsterdam UMC, location AMCRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Percutaneous Nephrostomy

Double J catheter

Arm Description

drainage of the kidney by means of a percutaneous Nephrostomy

drainage of the kidney by means of a double J catheter

Outcomes

Primary Outcome Measures

time (hours) to clinical recovery regarding infection
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) - If indication for drainage is infection clinical recovery is defined as: improvement of infection, indicated by a decrease of WBC (unit: mm3) in two executive laboratory results and at least below 15.000 mm3.
time (hours) to clinical recovery regarding infection
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) - If indication for drainage is infection clinical recovery is defined as: improvement of infection, indicated by a body temperatur between 36.0-38.5 °Celsius. and/or If indication for drainage is untreatable pain: Numeric rating score (NRS) considering pain resulting from a renal colic is improved and < 3 points and/or If indication for drainage is deterioration of kidney function: improvement of creatinine/ Glomerular Filtration Rate (GFR) in two executive laboratory results
time (hours) to clinical recovery regarding pain
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) If indication for drainage is untreatable pain clinical recover is defined as: Numeric Rating Score (NRS) considering pain resulting from a renal colic is improved and < 3 points (higher scores mean greater level of pain).
time (in hours) to clinical recovery regarding kidney function
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) If indication for drainage is deterioration of kidney function: improvement of creatinine (μmol/L) and/or Glomerular Filtration Rate (ml/min/1.73 m2) in two executive laboratory results.

Secondary Outcome Measures

patient reported outcome measures (PROMS) quality of life
EQ-5D-5L questionnaire (range 0-1; greater scores reflect a higher quality of life).
patient reported outcome measures (PROMS) pain score
Numeric Rating Score (NRS) considering pain questionnaire (range 0-10; greater scores reflect higher pain levels)
patient reported outcome measures (PROMS) satisfaction
satisfaction scale (range 0-10; greater scores reflect higher levels of satisfaction)
patient reported outcome measures (PROMS) catheter related problems
catheter questionnaire. All answers will be analysed using frequencies. No score is applicable.
patient reported outcome measures (PROMS) cost and productivity
disease-specified iMCQ (Medical Consumption Questionnaire)/iPCQ (Productivity Cost Questionnaire). All answers will be analyzed using frequencies and will be used in economical models to calculate productivity burden and societal and individual costs.
patient reported outcome measures (PROMS) on costs iMCQ (Medical consumption questionnaire)
disease-specified iMCQ (Medical Consumption Questionnaire). All answers will be analyzed using frequencies and will be used in economical models to calculate productivity burden and societal and individual costs.
patient reported outcome measures (PROMS) productivity
iPCQ (Productivity Cost Questionnaire). All answers will be analyzed using frequencies and will be used in economical models to calculate productivity burden and societal and individual costs.

Full Information

First Posted
July 16, 2020
Last Updated
October 19, 2020
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators
Alrijne Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04594161
Brief Title
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
Acronym
STONE
Official Title
Effectiveness of Drainage of the Kidney by Percutaneous Nephrostomy Catheter Placement Vs. Retrograde Double J Catheter Placement in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 15, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Anticipated)
Study Completion Date
March 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborators
Alrijne Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To investigate the effectiveness of percutaneous nephrostomy catheter placement versus retrograde double J catheter placement in patients with symptoms of obstructive kidney disease (with either infection and/or pain and/or kidney function deterioration) caused by urolithiasis.
Detailed Description
SUMMARY Rationale If a stone obstructs the ureter and impairs urine-efflux from the kidney this may cause infection, pain resulting from a renal colic and/or renal impairment. Drainage of the kidney may be necessary and can be established by placement of either a percutaneous nephrostomy (PCN) or a retrograde double J catheter (JJ). Considering method of drainage, setting, room in which drainage procedures takes place and anesthesia method, there are in fact 16 different approaches for drainage available, each with its own consequences for the patient and on expenses. Although evidence is poor, both methods of drainage are to be considered as equal.[1] This is reflected by the differences in preference between different countries.[2] In 2016 the Dutch association for urology (Nederlandse Vereniging voor Urologie (NVU)) marked this subject as one of the primary knowledge gaps in urology in The Netherlands and gave it priority on the national knowledge agenda for urology.[3] From patients' as well as from societal perspective it is of importance that the decision for placement of either PCN or JJ will be made based on evidence based arguments and in a uniform way. Hypothesis: Percutaneous nephrostomy is non inferior to retrograde double J catheter regarding time to clinical recovery. Secondly, patient reported outcome measures (PROMS) comparing treatment room and OR settings of drainage procedures will most likely not be significantly different. Finally, because percutaneous nephrostomy catheters are more often placed in a (outpatient) urological or radiological treatment room, this is expected to be less expensive than placement of a double J catheter (more often placed in the OR). Objective: To investigate the effectiveness of percutaneous nephrostomy catheter placement versus retrograde double J catheter placement in patients with symptoms of obstructive kidney disease (with either infection and/or pain and/or kidney function deterioration) caused by urolithiasis. Study design: Multicenter prospective randomized controlled non-inferiority trial. Study population: Male and female adult patients with signs of obstructive kidney disease with kidney or ureteral lithiasis as an underlying cause and with an indication for drainage based on symptoms of or laboratory tests indicating infection and/or pain and/or kidney function. Intervention: One group receives drainage by percutaneous nephrostomy catheter placement as opposed to the other group which will receive drainage by retrograde double J catheter placement. Main study parameters/endpoints: The primary objective is to assess whether a PCN is non-inferior to double J catheter regarding time to clinical recovery in patients with obstructive kidney disease resulting from urolithiasis. The primary outcome parameter is time to clinical recovery. Clinical recovery is defined as reaching one or more of the following criteria. The mandatory amount of criteria to achieve clinical recovery is dependent on the indication for placement of a PCN or a JJ. If indication for drainage is infection: improvement of infection, indicated by a decrease of WBC in two executive laboratory results and below 15.000 mm3 and a body temperature of 36-38.5 C. and/or If indication for drainage is untreatable pain: Numeric rating score (NRS) considering pain resulting from a renal colic is improved and < 3 points and/or If indication for drainage is deterioration of kidney function: improvement of creatinine/ Glomerular Filtration Rate (GFR) in two executive laboratory results It may occur that the indication for drainage is a combination of the above named indications. Clinical recovery will then be reached in case all parameters related to the different indications are within the set range. Secondary outcomes are further clinical data, PROMS (measured by the EQ-5D-5L, NRS, a satisfaction scale and a catheter questionnaire) and societal costs (measured by a diseasespecified iMCQ questionnaire). Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The placement of either PCN or double J catheter is standard care. Currently the choice for PCN or a double J catheter is based on expert opinion and may be driven by arguments considering logistics or assumptions about the quality of life for a patient after placement. Considering the difference in rate of placement of both PCN and double J catheter between various hospitals and different countries, it is believed experts have no uniform work method to handle the dilemma of choosing between these two techniques.[2] Furthermore the current EAU-guideline 2018 states that both methods of drainage are to be considered as equal.[1] Therefore there is no reason to believe, patients will be affected negatively by being placed randomly in either the double J group or the PCN group. Questionnaires will be filled in daily during hospitalization and twice or less afterwards. This is not considered to be a risk for the patient. The longest questionnaires (EQ-5D-5L and iMCQ) will take approximately 10-20 minutes to fill in, additional to the shorter scales (NRS, satisfaction scale) which will take approximately 1 minute to fill in. Generally It will take 90 minutes, spread over the course of three months, to fill in all questionnaires. For frequency and timing of the questionnaires. Finally, no additional visits to a hospital, withdrawal of blood samples or exposure to radiation is to be expected when taking part in this study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urolithiasis, Urologic Diseases, Urinary Calculi, Urinary Obstruction, Urinary Stone, Ureteric Obstruction, Calculus Ureteral, Stone Ureter, Stone;Renal, Stone, Kidney, Stone, Urinary, Obstruction Ureter, Obstruction, Ureter Calculi, Ureter Obstruction, Kidney Diseases, Kidney Calculi, Kidney Failure, Acute, Kidney Dysfunction, Kidney Insufficiency, Pyelonephritis, Pyelonephritis Acute, Pyelonephritis Obstructive, Pyelonephritis; Calculus, Pyelonephritis; Obstruction, Pyelonephrosis, Hydronephrosis, Hydronephrosis; Infection, Hydronephrosis, Infected, Hydronephrosis; Obstruction, Ureter, Hydronephrosis; Obstruction, Renal Calculus, Hydronephrosis, Secondary, Renal Pelvis; Obstruction
Keywords
Urolithiasis, Urologic Diseases, Urinary Calculi, Urinary Obstruction, Urinary Stone, Nephrostomy; Complications, Catheter Complications, double j catheter, JJ catheter, urinary stent, percutaneous nephrostomy, stent

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised controlled trial
Masking
None (Open Label)
Masking Description
No masking is possible because stent is visible to patient and physician
Allocation
Randomized
Enrollment
204 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Percutaneous Nephrostomy
Arm Type
Active Comparator
Arm Description
drainage of the kidney by means of a percutaneous Nephrostomy
Arm Title
Double J catheter
Arm Type
Active Comparator
Arm Description
drainage of the kidney by means of a double J catheter
Intervention Type
Device
Intervention Name(s)
Percutaneous Nephrostomy
Other Intervention Name(s)
PCN, Nephrostomies, Percutaneous, Percutaneous Nephrostomies, Nephrostomy
Intervention Description
A Percutaneous Nephrostomy will be placed in patients with obstructive urolithiasis
Intervention Type
Device
Intervention Name(s)
Double J catheter
Other Intervention Name(s)
stent, JJ, internal stent, JJ catheter, urinary stent, internal urinary stent, ureteral stent, internal ureteral stent, internal ureteric stent, ureteric stent, ureteral stents, internal ureteral stents, internal ureteric stents, ureteric stents, double j ureteral catheter, double-j catheter, internalized double-j catheter
Intervention Description
A Double J catheter will be placed in patients with obstructive urolithiasis
Primary Outcome Measure Information:
Title
time (hours) to clinical recovery regarding infection
Description
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) - If indication for drainage is infection clinical recovery is defined as: improvement of infection, indicated by a decrease of WBC (unit: mm3) in two executive laboratory results and at least below 15.000 mm3.
Time Frame
3 months
Title
time (hours) to clinical recovery regarding infection
Description
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) - If indication for drainage is infection clinical recovery is defined as: improvement of infection, indicated by a body temperatur between 36.0-38.5 °Celsius. and/or If indication for drainage is untreatable pain: Numeric rating score (NRS) considering pain resulting from a renal colic is improved and < 3 points and/or If indication for drainage is deterioration of kidney function: improvement of creatinine/ Glomerular Filtration Rate (GFR) in two executive laboratory results
Time Frame
3 months
Title
time (hours) to clinical recovery regarding pain
Description
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) If indication for drainage is untreatable pain clinical recover is defined as: Numeric Rating Score (NRS) considering pain resulting from a renal colic is improved and < 3 points (higher scores mean greater level of pain).
Time Frame
3 months
Title
time (in hours) to clinical recovery regarding kidney function
Description
Unit is hours (0-∞), higher scores mean a worse outcome. Clinical recovery is defined as reaching one or more of the following criteria (all criteria are added seperately) If indication for drainage is deterioration of kidney function: improvement of creatinine (μmol/L) and/or Glomerular Filtration Rate (ml/min/1.73 m2) in two executive laboratory results.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
patient reported outcome measures (PROMS) quality of life
Description
EQ-5D-5L questionnaire (range 0-1; greater scores reflect a higher quality of life).
Time Frame
3 months
Title
patient reported outcome measures (PROMS) pain score
Description
Numeric Rating Score (NRS) considering pain questionnaire (range 0-10; greater scores reflect higher pain levels)
Time Frame
3 months
Title
patient reported outcome measures (PROMS) satisfaction
Description
satisfaction scale (range 0-10; greater scores reflect higher levels of satisfaction)
Time Frame
3 months
Title
patient reported outcome measures (PROMS) catheter related problems
Description
catheter questionnaire. All answers will be analysed using frequencies. No score is applicable.
Time Frame
3 months
Title
patient reported outcome measures (PROMS) cost and productivity
Description
disease-specified iMCQ (Medical Consumption Questionnaire)/iPCQ (Productivity Cost Questionnaire). All answers will be analyzed using frequencies and will be used in economical models to calculate productivity burden and societal and individual costs.
Time Frame
3 months
Title
patient reported outcome measures (PROMS) on costs iMCQ (Medical consumption questionnaire)
Description
disease-specified iMCQ (Medical Consumption Questionnaire). All answers will be analyzed using frequencies and will be used in economical models to calculate productivity burden and societal and individual costs.
Time Frame
3 months
Title
patient reported outcome measures (PROMS) productivity
Description
iPCQ (Productivity Cost Questionnaire). All answers will be analyzed using frequencies and will be used in economical models to calculate productivity burden and societal and individual costs.
Time Frame
3 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - In order to be considered eligible to participate in this study, a subject must meet all of the following criteria: Male/female >18 year Symptoms and/or laboratory results indicating obstructive kidney disease with or without infection. A kidney or ureteral stone is present on ultrasound or CT (max 3 months old prior to presentation) Both drainage techniques are feasible and safe in opinion of the treating physician (from logistics point of view and in the best interest of the patient). Willing and able to comply with filling in questionnaires and follow-up regiment Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: Analphabetic or not mastering the Dutch language Pregnancy Usage of anticoagulation agents other than acetylsalicylic acid. Contraindication for either technique looking at history and anatomy (e.g. kidney transplant, pouch, Bricker deviation, urethral or ureteral stenosis)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Barbara Schout, dr.
Phone
+31 715828282
Email
bmaschout@alrijne.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Nora Hendriks, Drs.
Phone
+31636571112
Email
nhendriks@alrijne.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ad Hendrikx, dr.
Organizational Affiliation
no affiliation
Official's Role
Study Chair
Facility Information:
Facility Name
Amsterdam UMC, location AMC
City
Amsterdam
State/Province
Noord Holland
ZIP/Postal Code
1105 AZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
H.P. R Beerlage, prof. dr.
Phone
+31(0)20-5669111
Email
h.p.beerlage@amsterdamumc.nl

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
https://zorgevaluatienederland.nl/stone
Description
official dutch website

Learn more about this trial

Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis

We'll reach out to this number within 24 hrs